ALK INHIBITORS

被引：0
|
作者：
Blackhall, F. [1 ]
机构：
[1] Christie NHS Fdn Trust, Manchester, Lancs, England
来源：
JOURNAL OF THORACIC ONCOLOGY | 2012年 / 7卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S20 / S21
页数：2
相关论文
共 50 条
  • [31] ACQUIRED RESISTANCE TO ALK TYROSINE KINASE INHIBITORS
    Sasaki, T.
    Ohsaki, Y.
    Pasi, J.
    ANNALS OF ONCOLOGY, 2012, 23 : 80 - 80
  • [32] RESISTANCE TO ALK INHIBITORS IN NEUROBLASTOMA IS REGULATED BY BORIS
    不详
    CANCER DISCOVERY, 2019, 9 (10) : 1335 - 1335
  • [33] Synthesis of novel ALK5 inhibitors
    Hall, Thomas
    Kelsey, Lauren
    Streu, Craig
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
  • [34] Synthetic approach to novel NMP/ALK inhibitors
    Zambon, A
    Goekjian, P
    Lucchini, V
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 28 : S24 - S24
  • [35] Novel ALK inhibitors in clinical use and development
    Iragavarapu, Chaitanya
    Mustafa, Milaim
    Akinleye, Akintunde
    Furqan, Muhammad
    Mittal, Varun
    Cang, Shundong
    Liu, Delong
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2015, 8
  • [36] An update of ALK inhibitors in human clinical trials
    Chan, Eason Leong Yin
    Chin, Claudia Ho Yi
    Lui, Vivian Wai Yan
    FUTURE ONCOLOGY, 2016, 12 (01) : 71 - 81
  • [37] ALK TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF NHL
    Morris, S. W.
    ANNALS OF ONCOLOGY, 2011, 22 : 113 - 113
  • [38] Novel ALK inhibitors in clinical use and development
    Chaitanya Iragavarapu
    Milaim Mustafa
    Akintunde Akinleye
    Muhammad Furqan
    Varun Mittal
    Shundong Cang
    Delong Liu
    Journal of Hematology & Oncology, 8
  • [39] ALK inhibitors, resistance development, clinical trials
    Rothenstein, J. M.
    Chooback, N.
    CURRENT ONCOLOGY, 2018, 25 : S59 - S67
  • [40] EML4/ALK and Ras Inhibitors
    Edelman, Martin J.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S495 - S496
12345